Deep Learning CAD Screening on Chest CT
Recruiting now
Conditions studied: Coronary Artery Disease, Coronary Artery Stenosis Stent
In brief
Coronary artery disease (CAD) is one of the leading causes of death worldwide. Many people have early atherosclerosis without symptoms, and some may develop significant coronary stenosis before any warning signs appear. Identifying high-risk individuals at an early stage is important to prevent heart attacks and other cardiovascular events. Coronary CT angiography (CCTA) can directly evaluate plaque type and the degree of narrowing in the coronary arteries, but it is expensive, requires contrast injection, and involves higher radiation, making it unsuitable for large-scale screening. In contrast, non-contrast chest CT is widely used for health check-ups and lung disease follow-up. Such scans often provide clear views of certain coronary segments, which creates an opportunity to screen for CAD without additional cost or risk. This multicenter study aims to develop and validate deep learning models to analyze coronary calcified segments that are visible on non-contrast chest CT. Two main objectives are: (1) to predict whether calcified segments contain mixed plaque components (both calcified and non-calcified); and (2) to predict whether these segments have significant narrowing (≥50% stenosis) as determined by CCTA. The study will also describe how often ≥50% stenosis is found in non-calcified segments, in order to demonstrate their low-risk nature. The study includes retrospective data collected between 2015 and 2024, and a prospective external validation cohort starting in 2025. Approximately 1,417 patients with paired chest CT and CCTA have already been included for model development and testing. An additional 200 or more patients will be prospectively recruited for external validation. This research may provide evidence that deep learning applied to routine non-contrast chest CT can serve as an opportunistic tool for early CAD risk screening in the general population.
Key facts
- Study ID
- NCT07181512
- Run by
- Yifan Guo
- People needed
- 200
- Starts
- 2025-09-01
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-02-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age ≥18 years
- Patients who underwent both non-contrast chest CT and coronary CT angiography (CCTA) within 30 days
- Coronary segments clearly visualized on non-contrast chest CT
You may not qualify if…
- Segments with motion artifacts, metal artifacts, or stents preventing analysis
- Vessel lumen completely obscured by calcification (unrecognizable vascular course)
- Inability to match coronary segment location between non-contrast chest CT and CCTA
Where it is running
- The First Affiliated Hospital of Zhejiang Chinese Medical University — Hangzhou, Zhejiang, China (enrolling)
- The First Affiliated Hospital of Ningbo University — Ningbo, Zhejiang, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.